Genpharmasec Ltd

Genpharmasec Ltd’s shares declined to a fresh 52-week low of Rs.1.24 on 9 Jan 2026, marking a significant drop amid persistent underperformance relative to its sector and benchmark indices.

Genpharmasec Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 07 January 2026, providing investors with the latest comprehensive view of the company’s position.

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Genpharmasec has reached a new 52-week low of Rs.1.29, marking a significant decline in its share price amid a persistent downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing challenges in its financial performance and market positioning.

Genpharmasec's stock price reached a new 52-week low of Rs.1.3 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock's current trading levels reflect ongoing challenges within the Trading & Distributors sector, contrasting with the relatively stable performance of benchmark indices.

Genpharmasec, a company operating in the Trading & Distributors sector, has reached a new 52-week low of Rs.1.34 today, marking a significant decline in its stock price amid broader market dynamics and company-specific factors.

Genpharmasec, a microcap player in the Trading & Distributors sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a period marked by notable stock price declines and mixed fundamental indicators.

Genpharmasec has reached a new 52-week low, closing at Rs.1.37, marking a significant decline amid persistent downward momentum over recent sessions. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Trading & Distributors sector.

Genpharmasec has reached a new 52-week low of Rs.1.41, marking a significant decline in its share price amid a challenging market environment and subdued financial performance over the past year.

Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite reporting positive quarterly results, the company's long-term fundamentals remain weak, with challenges in debt servicing and consistent underperformance compared to the broader market.

Genpharmasec Ltd., a micro-cap trading and distribution company, reported a net profit of ₹1.22 crores for Q2 FY26, marking a dramatic 269.70% year-on-year surge from ₹0.33 crores in Q2 FY25. However, this headline figure conceals a troubling sequential decline, with profits plunging 551.85% quarter-on-quarter from a loss of ₹0.27 crores in Q1 FY26. The company's shares, currently trading at ₹1.52, have collapsed 50.97% over the past year, reflecting deep-seated investor concerns about the sustainability of its business model and deteriorating financial health.

Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a 50% decline over the past year. Despite a recent performance improvement, the stock struggles below key moving averages and faces challenges with long-term financial strength and debt servicing capabilities, despite a notable increase in net sales.

Genpharmasec has reached a new 52-week low, marking a significant downturn after a five-day decline. The stock is trading below multiple moving averages and has underperformed over the past year. Despite a substantial increase in operating profit, long-term fundamentals and debt servicing capabilities raise concerns.

Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a challenging year with a significant decline in stock performance. Despite outperforming its sector recently, the stock remains below key moving averages, indicating ongoing struggles in profitability and long-term performance.